skip to Main Content
large burst
light ray
upper burst
square

Unlock the
power of proteins

Apply our revolutionary CodeEvolver® platform technology to deliver high-performing enzymes and customized solutions in a wide array of applications.

Watch the video
blue-dna

Pharmaceuticals

Improve production processes with state-of-the-art enzymes.

Learn More

adam-staring-at-petri-dish

Biotherapeutics

Create novel therapeutic proteins with highly optimized performance.

Learn More

Sugar_enzyme

Food & Beverage

Impact product quality and profitability with expert protein engineering.

Learn More

blockquote

“The partnership with Codexis strengthens our footprint in the enzyme field, a fast-developing part of the nutritional therapy innovation frontier that is changing the way we manage our health.”

Greg Behar, CEO
Nestlé Health Science

“[Codexis’] process, which won a 2010 Presidential Green Chemistry Award, increased sitagliptin yield, cut back on production steps, and reduced water use and waste. The advance led to a threefold increase in productivity and helped us avoid the cost of building a second factory to meet rising demand for Januvia.”

R.P. "Skip" Volante, Vice President of R&D
Merck

“We chose the Codexis platform after a thorough evaluation of the enzyme evolution landscape. Codexis has a significant track record of delivering evolved biocatalysts for pharmaceutical and fine chemical applications over an extended period of time.”

Doug Fuerst, Technology Development Lead, Synthetic Biology
GlaxoSmithKline

“We view Codexis as an extension of our internal research and development programs at Tate & Lyle and are excited about the opportunities which this partnership brings to deliver new and innovative food ingredients to the market.”

Michael Harrison, Senior Vice President of New Product Development
Tate & Lyle

Latest News

19Feb 13

Strem and Codexis Sign Enzyme Distribution Agreement

NEWBURYPORT, Mass. & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Feb. 19, 2013– Strem Chemicals, Inc., a manufacturer of specialty chemicals for research and development and Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals,…
read more
15Feb 13

Codexis to Participate in Informex USA 2013 Conference

-Company to Highlight its Enzymatic Technology Breakthroughs and Market Opportunities in Fine Chemicals Sector- REDWOOD CITY, Calif.–(BUSINESS WIRE)–Feb. 15, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and…
read more
13Feb 13

AMRI and Codexis Announce Technology Collaboration

SMARTSOURCING™ Partnership to Focus on Improved Process Development Download PDF Albany, NY and Redwood City, CA (February 13, 2013) — AMRI (NASDAQ: AMRI) and Codexis (NASDAQ: CDXS) announced today that they have entered into a SMARTSOURCING™ partnership. The…
read more
Back To Top
Close search
Search